Genotype-Guided Hydralazine Therapy is a research paper published in American Journal of Nephrology (2020). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: K08 DK107864
NHGRI NIH HHS
Grant: U01 HG010245
NIGMS NIH HHS
Grant: T32 GM008425
NHGRI NIH HHS
Grant: U01 HG007269
National Institutes of Health
Grant: 5U01HG007269-02
Genomic Medicine Implementation: The Personalized Medicine Program
National Institutes of Health
Grant: 5T32GM008425-09
CLINICAL PHARMACOLOGY TRAINING GRANT
National Institutes of Health
Grant: 3U01HG010245-05S2
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.
National Institutes of Health
Grant: 5K08DK107864-05
Acute inhibition of renal gene expression to prevent nephrotoxicity.
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals